Last 17.80
Change Today +0.30 / 1.71%
Volume 500.0
As of 3:15 AM 07/28/14 All times are local (Market data is delayed by at least 15 minutes).

elbit medical technologies l (EMTC) Snapshot

Open
$17.80
Previous Close
$17.50
Day High
$17.80
Day Low
$17.80
52 Week High
03/18/14 - $28.50
52 Week Low
09/24/13 - $7.90
Market Cap
148.0M
Average Volume 10 Days
324.1K
EPS TTM
$-0.01
Shares Outstanding
831.4M
EX-Date
12/11/06
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ELBIT MEDICAL TECHNOLOGIES L (EMTC)

Related News

No related news articles were found.

elbit medical technologies l (EMTC) Related Businessweek News

No Related Businessweek News Found

elbit medical technologies l (EMTC) Details

Elbit Medical Technologies Ltd. through its subsidiaries, offers development, production, and marketing of magnetic resonance imaging guided ultrasound equipment in Israel. It offers ExAblate, a system that is used to visualize the body anatomy, plan the treatment, and monitor treatment outcome in real time; and MR thermometry, a system that allows the physicians to control and adjust the treatment in real time. The company is based in Tel Aviv, Israel. Elbit Medical Technologies Ltd. operates as a subsidiary of Elbit Ultrasound (Netherlands) B.V.

elbit medical technologies l (EMTC) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

elbit medical technologies l (EMTC) Key Developments

Teva, Clal And Elbit Still Seek Buyer For Gamida Cell

Teva Pharmaceuticals Industries Limited (NYSE:TEVA), Clal Biotechnology Industries (TASE:CBI) and Elbit Medical Technologies Ltd. (TASE:EMTC) are still looking to sell Gamida Cell Ltd.

Novartis Reportedly Cancels Acquisition Of Gamida

Novartis AG (SWX:NOVN) decided not to approve the acquisition of Gamida Cell Ltd. from Elbit Medical Technologies Ltd. (TASE:EMTC) and Clal Biotechnology Industries (TASE:CBI), said sources. It is not clear what is Novartis's reason for pulling out of the transaction. Novartis had never publicly acknowledged that there were talks in the first place, although they had signed a memorandum of understanding including the exact financial conditions of the deal. It is unusual for a deal to reach such an advanced stage and not be realized, even though this was a very advanced deal and it was related to future strategic directions.

Elbit Medical Technologies Ltd. Auditor Raises 'Going Concern' Doubt

Elbit Medical Technologies Ltd. filed its Annual on Mar 27, 2014 for the period ending Dec 31, 2013. In this report its auditor, Brightman Almagor Zohar & Co, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EMTC:IT 17.80 +0.30

EMTC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for EMTC.
View Industry Companies
 

Industry Analysis

EMTC

Industry Average

Valuation EMTC Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ELBIT MEDICAL TECHNOLOGIES L, please visit www.elbitimaging.com/126-en/Elbit-Imaging.aspx. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.